Plant-Derived Modulators of Tumor Metabolism as Novel, Efficacious, and Low-Toxicity Therapeutic Agents for Cancer Treatment
Molecules · 23.04.2026 · 31 (9) · 1394
DOI: 10.3390/molecules31091394 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 23.04.2026. Verfasst von Tania Mmapule Maphoso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Level 7, Bridge E, Steve Biko Academic Hospital, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Afri…. Hauptthemen laut MEDLINE: Neoplasms, Phytochemicals, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council.
Abstract (Originalsprache)
Metabolic reprogramming is a core hallmark of malignancy, enabling tumor cells to sustain rapid proliferation, evade immune elimination, and develop resistance to therapy. Although a wide range of plant-derived phytochemicals exhibit anticancer activity with comparatively low toxicity, their capacity to disrupt specific metabolic dependencies exploited by tumors has not been comprehensively synthesized. This review brings together current mechanistic evidence showing how major phytochemical classes, including polyphenols, terpenes and terpenoids, glucosinolates, and alkaloids, interfere with pathways central to tumor metabolic fitness, such as aerobic glycolysis, pentose phosphate pathway flux, mitochondrial substrate oxidation, glutamine dependence, and redox homeostasis. It further introduces a pathway-focused framework that links phytochemical mechanisms to quantifiable metabolic outcomes and highlights their potential to remodel the tumor microenvironment by altering nutrient competition, oxidative stress responses, and hypoxia-driven signaling. Key barriers such as poor systemic bioavailability, rapid metabolic degradation, and limited tissue penetration are assessed alongside emerging formulation and delivery strategies designed to enhance therapeutic exposure while preserving low-toxicity profiles. Mapping these mechanistic insights onto clinical development needs allows prioritization of specific phytochemical-metabolic pathway pairs with the strongest potential for translation. This positions plant-derived metabolic disruptors as promising candidates for next-generation, low-toxicity anticancer therapies that strategically exploit defined metabolic vulnerabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Level 7, Bridge E, Steve Biko Academic Hospital, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.
- Biodiscovery Centre, Department of Chemistry, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0028, South Africa.
- Nuclear Medicine Research Infrastructure NPO, Level 4, Steve Biko Academic Hospital, Pretoria 0001, South Africa.
- Department of Nuclear Medicine, Level 5, Steve Biko Academic Hospital, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.
- South African Nuclear Energy Corporation, Elias Motsoaledi St., R104 Pelindaba, Brits Municipality, Pretoria 0240, South Africa.
ORCID-Profile: Tania Mmapule Maphoso, Dakalo Portia Ramali, Thanyani Mulaudzi, Vinesh Maharaj, Botle Precious Damane
Förderung
- South African Medical Research Council
Zitieren
APA
Maphoso, T. M., Ramali, D. P., Mulaudzi, T., Maharaj, V., Driver, C. H. S., & Damane, B. P. (2026). Plant-Derived Modulators of Tumor Metabolism as Novel, Efficacious, and Low-Toxicity Therapeutic Agents for Cancer Treatment. Molecules, 31(9), 1394. https://doi.org/10.3390/molecules31091394
Vancouver
Maphoso TM, Ramali DP, Mulaudzi T, Maharaj V, Driver CHS, Damane BP. Plant-Derived Modulators of Tumor Metabolism as Novel, Efficacious, and Low-Toxicity Therapeutic Agents for Cancer Treatment. Molecules. 2026;31(9):1394. doi:10.3390/molecules31091394
BibTeX
@article{Maphoso2026,
author = {Maphoso, Tania Mmapule and Ramali, Dakalo Portia and Mulaudzi, Thanyani and Maharaj, Vinesh and Driver, Cathryn Helena Stanford and Damane, Botle Precious},
title = {Plant-Derived Modulators of Tumor Metabolism as Novel, Efficacious, and Low-Toxicity Therapeutic Agents for Cancer Treatment},
journal = {Molecules},
year = {2026},
volume = {31},
number = {9},
pages = {1394},
doi = {10.3390/molecules31091394}
}
EUVIMED